In the news

Single test for COVID-19 and influenza now available to all providers

Feb. 4, 2021

Mayo Clinic Laboratories now offers multiplex testing for SARS-CoV-2 (the virus that causes COVID-19) and influenza A and B to all health care providers.

The test, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA and Influenza Virus Type A and Type B RNA Detection (Test ID: COFLU), is used to detect and differentiate between COVID-19 and influenza A and B in a single test using upper respiratory tract specimens. Test results should always be considered in the context of a patient’s clinical history, physical examination, and epidemiologic exposures when making the final diagnosis.

Mayo Clinic Laboratories also has a full menu of COVID-19 molecular tests, serology tests, and other COVID-19-related testing.

Hannah Crawford (@hannahcrawford)

Hannah Crawford

Hannah Crawford is content marketing manager at Mayo Clinic Laboratories. She focuses on telling stories about the impact of laboratory medicine for patients and health care organizations around the world. Hannah has worked at Mayo Clinic Laboratories since 2018.